Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Lewy bodies; and very common findings: Amyotrophic lateral sclerosis. 8 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Memory problems (memory impairment), Frontotemporal dementia, Aphasia |
TIA1 function has not been fully characterized.
Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia has limited evidence linking it to mutations in the TIA1 gene on chromosome 2.
Genetic testing for TIA1 is available. Testing is considered research-grade for diagnosis.
Biomarker and diagnostic research for amyotrophic lateral sclerosis 26 with or without frontotemporal dementia has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 1 very common feature, 3 common features.
No clinical trials have been registered for amyotrophic lateral sclerosis 26 with or without frontotemporal dementia.
204 publications have been identified in PubMed for amyotrophic lateral sclerosis 26 with or without frontotemporal dementia. Research spans Basic Science / Preclinical (32%), Review / Meta-Analysis (31%), and Diagnostic / Biomarker (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 56 | 32% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 6:22 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about amyotrophic lateral sclerosis 26 with or without frontotemporal dementia
1 |
Limb muscle weakness |
Arms and legs | 1 | Limb muscle weakness |
Research summaries |
54 |
31% |
Testing and diagnosis research | 26 | 15% |
Disease patterns and progression | 21 | 12% |
New treatment approaches | 7 | 4% |
Patient case studies | 6 | 3% |
Clinical study results | 4 | 2% |
Other research | 3 | 2% |
Chu M (2026). [PMID: 41866346](https://pubmed.ncbi.nlm.nih.gov/41866346/). *Alzheimers Dement*. [Diagnostic / Biomarker]
Smith JE (2026). [PMID: 41785337](https://pubmed.ncbi.nlm.nih.gov/41785337/). *Science*. [Basic Science / Preclinical]
Silva-Llanes I (2026). [PMID: 41486173](https://pubmed.ncbi.nlm.nih.gov/41486173/). *J Biomed Sci*. [Basic Science / Preclinical]
Casile A (2026). [PMID: 41997556](https://pubmed.ncbi.nlm.nih.gov/41997556/). *Neuroscience*. [Review / Meta-Analysis]
Mir HD (2026). [PMID: 41524247](https://pubmed.ncbi.nlm.nih.gov/41524247/). *FASEB J*. [Basic Science / Preclinical]
Maskell KG (2026). [PMID: 41498587](https://pubmed.ncbi.nlm.nih.gov/41498587/). *Lab Chip*. [Review / Meta-Analysis]
Chalitsios CV (2026). [PMID: 41165081](https://pubmed.ncbi.nlm.nih.gov/41165081/). *Ann Neurol*. [Epidemiology / Natural History]
Moret S (2026). [PMID: 41918511](https://pubmed.ncbi.nlm.nih.gov/41918511/). *Yale J Biol Med*. [Review / Meta-Analysis]
James RE (2026). [PMID: 41061670](https://pubmed.ncbi.nlm.nih.gov/41061670/). *Brain*. [Gene Therapy / Novel Therapeutics]
Liu Y (2026). [PMID: 41912662](https://pubmed.ncbi.nlm.nih.gov/41912662/). *Nat Neurosci*. [Basic Science / Preclinical]